Financials
Income statement
Fiscal date | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
---|---|---|---|---|
Total reported revenue | 11.4B | 15.9B | 20.0B | 196.1B |
Cost of revenue | 7.9B | 9.5B | 14.8B | 145.5B |
Gross profit | 3.5B | 6.3B | 5.2B | 50.6B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 255.8M | 51.9M | 2.0B | 2.7B |
Other operating expenses | 605.9M | 908.6M | 433.0M | -2.5B |
Operating income | 1.1B | 1.4B | -890.9M | 51.9B |
Non operating interest income | ||||
Income | 3.2B | 1.9B | 4.5B | 13.9B |
Expense | 209.8M | 191.0M | 243.2M | -22.9B |
Other income expense | — | — | — | — |
Pretax income | 4.2B | 1.4B | 4.7B | 88.3B |
Tax provision | 713.2M | 322.5M | 1.1B | 3.7B |
Net income | 3.5B | 1.1B | 3.7B | 84.7B |
Basic EPS | — | — | 1.2 | — |
Diluted EPS | — | — | 1.2 | — |
Basic average shares | — | — | 3.2B | — |
Diluted average shares | — | — | 3.2B | — |
EBITDA | 4.9B | 2.3B | 5.7B | 66.1B |
Net income from continuing op. | — | — | — | — |
Minority interests | -21.3K | -24.4M | 128.4M | 51.9M |
Preferred stock dividends | 0 | 0 | 0 | 0 |